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Vegetable oils present important pharmacological properties, which gained ground in the pharmaceutical 
field. Its encapsulation in nanoemulsions is considered a promising strategy to facilitate the applicability 
of these natural compounds and to potentiate the actions. These formulations offer several advantages for 
topical and systemic delivery of cosmetic and pharmaceutical agents including controlled droplet size, 
protection of the vegetable oil to photo, thermal and volatilization instability and ability to dissolve and 
stabilize lipophilic drugs. For these reasons, the aim of this review is to report on some characteristics, 
preparation methods, applications and especially analyze recent research available in the literature 
concerning the use of vegetable oils with therapeutic characteristics as lipid core in nanoemulsions, 
specially from Brazilian flora, such as babassu (Orbignya oleifera), aroeira (Schinus molle L.), andiroba 
(Carapa guaianiensis), casca-de-anta (Drimys brasiliensis Miers), sucupira (Pterodon emarginatus 
Vogel) and carqueja doce (Stenachaenium megapotamicum) oils.
Uniterms: Plant oils/nanoemulsions/preparation. Plant oils/biological applications.
INTRODUCTION
The use of submicrometric colloidal nanocarriers 
such as nanoparticles (NP) lipid and polymeric, 
nanoemulsions (NE), microemulsions (ME), liposomes, 
and polymeric micelles is considered a promising system 
in the pharmaceutical field, because they have numerous 
advantages over traditional formulations such as: sustained 
release of the active element; solubilization of lipophilic 
molecules; use for different routes of administration; 
protection from chemical and enzymatic degradation 
of labile molecules; reduction of vegetable oils (VO) 
volatilization, side effects and dose (Mäder, Mehnert, 
2005; Mehnert, Mäder, 2001; Gref, Couvreour, 2006; 
Couvreur, Vauthier, 2006; Panyam, Labhasetwar, 2003; 
Soppimath et al., 2001; Ai et al., 2011; Contri et al., 2012; 
Contri et al., 2014; Dimer et al., 2014; Severino et al., 
2015; Frank et al., 2015; Asbahani et al., 2015). However, 
all systems differ thermodynamic stability, structure, 
chemical composition, efficiency encapsulation and types 
of application (Mäder, Mehnert, 2005; Ai et al., 2011).
The development of suitable nanocarriers for 
pharmaceutical or cosmetic application requires the 
adequate selection of their adjuvants such as polymers for 
nanocapsules (NC), surfactants, and oils (Schaffazick et 
al., 2003; Alvarez-Román et al., 2001; Bouchemal et al., 
2004; Friedrich et al., 2008). Recently, special attention 
has been given to the type of oily phase used as the core 
in the preparation of NE. VO has been preferred not 
only due to the concept that it is safe and biocompatible, 
but mainly because of the diversity of benefits, and the 
complex composition of fatty acids can exercise under 
the skin, protecting it against dehydration, solar radiation, 
inflammation, insect attack, microorganisms, and viruses 
(Tadros, Kessell, 2004; Bloise, 2003; Oyedeji, Okeke, 
2010; Bakkali et. al., 2008; Harris, 2002; Contri et al, 
2012; Hilbig et al., 2016). In comparison to mineral 
oils, vegetable oils exhibit low viscosity and molecular 
weight, which makes them less occlusive (Silva, Soares, 
1996).
Due to the high susceptibility of VO to photo and 
thermal oxidation, it is very common for appearance 
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modification and allergic reactions to appear, caused under 
the skin by formulations with these compositions (Vigan, 
2010; Hammer et al., 2006; Sköld et al., 2002; Neumann, 
Garcia, 1992). Therefore, the safety of the active elements 
and the use is limited to increase the concentration of these 
oils in the formulations. These factors combined with low 
topical permeation due to the poor aqueous solubility 
limits the display of VO as candidates for dermatological 
treatments (São Pedro et al., 2013). For this reason, 
nanoencapsulation has been used as an alternative 
to increase the stability, efficacy, solubility, sensory 
character, and also the controlled release of natural assets 
through techniques involving nanotechnology (Chanchal, 
Swarnlata, 2008; Daudt et al., 2013; Flores et al, 2013; 
Flores et al, 2015; Severino et al., 2015; Asbahani et al., 
2015). This artifice allows the use of VO not only on the 
skin, but also in alternative routes of administration that 
include intravenous, oral and inhalatory forms (Roger et 
al., 2010; Thanki et al., 2013; Lai, Wang, Hanes, 2009; 
Kushwaha, Keshari, Rai, 2011; Singh et al., 2011).
VO with therapeutic potential have been widely 
used for pharmaceutical and cosmetic industries as oil core 
nanostructured systems to substitute for those of mineral 
origin, such as caprylic/capric triglyceride, for example 
(Ourique et al, 2008). One of the trends of the cosmetic 
market is the development of products with the largest 
number of components of natural origin, especially of 
plant origin, rationally exploiting Brazilian biodiversity. 
The incorporation of natural active ingredients in cosmetic 
products has been a common practice because there is a 
great interest in both the domestic and international market, 
especially if the raw material present in the scientific studies 
proves its safety and efficacy, in addition to the commitment 
to the sustainable development of VO (Franquilino, 2006).
Considering the therapeutic properties of VO and the 
various advantages of nanostructured systems, especially 
NE, several research studies have been developed and 
published in the scientific media. Natural products show 
complex characteristics and their inclusion can involve a 
mixture of a number of compounds, rendering it difficult 
to develop the formulation (Ribeiro et al., 2013). Thus, the 
objective of this study is to write a literature review about the 
research conducted so far on the advantages of using VO as 
an oil core in NE, as well as methods of preparation used, its 
physicochemical properties, and studies in vivo and in vitro.
METHODOLOGY
This research was performed at the following 
websites: National Center for Biotechnology Information 
(NCBI), Science Direct, Scientific Electronic Library 
Online (Scielo) and Scirus. The search terms used were: 
nanocarriers; drug delivery; nanoemulsions; oil-in-
water nanoemulsions; vegetable oils; oil core; review; 
applicability; Brazilian oil and therapeutical potential. 
Different combinations of two or three keywords were 
used to broaden the research articles from 1969 onwards. 
The research includes articles to 14/06/16.
General considerations about nanoemulsions
Among the colloidal nanostructures release of lipid 
nature that allow nanoencapsulation of VO and other 
active natural compounds for therapeutic and cosmetic 
purposes, are the NE. NE represent a class of emulsions 
with a diameter of less than one micrometer (50-200 
nm), low viscosity droplet, transparent or translucent 
appearance with intense bluish reflection or milky, 
depending on the size of the droplets (Constantinides, 
Chaubal, Shorr, 2008; Wang et al., 2009; Calderó, García-
Celma, Solans, 2011; Gupta et al., 2016; Hörmann, 
Zimmer et al., 2016). Frequently, NE are called ultrafine 
or submicrometric emulsion and mini-emulsions. These 
systems are fragile by nature and are usually very 
transparent and fluid, the slightest sign of destabilization 
becomes readily visible (Sonneville-Aubrun, Simonnet, 
L’alloret, 2004). As to composition, NE are oil-in-water 
(O/W) emulsions containing 10 to 20% oil stabilized 
with 0.5 to 2% surfactant and the active ingredients are 
preferably solubilized, dispersed and/or adsorbed onto 
the internal phase of the nanostructure (Wang et al., 2009; 
Calderó, García-Celma, Solans, 2011; Wang et al., 2009; 
Calderó, García-Celma, Solans, 2011; Garg, Kokkoli, 
2005; Maestro et al., 2008; Spinelli et al., 2010).
FIGURE 1 - Types of O/W NE: (A) NE with synthetic oil 
core, (B) NE with synthetic oil core and drug, (C) NE with 
therapeutically oil core, (D) NE with therapeutically oil core 
and drug. 
The use of Brazilian vegetable oils in nanoemulsions: an update on preparation and biological applications 349
The NE are kinetically stable due to their steric 
balance, especially when formulated with nonionic 
surfactants (Tadros et al., 2004; Gupta et al., 2016). Due 
to their small size droplets, they are resistant to being 
physically affected by creaming and sedimentation 
instability, because their Brownian motion that is 
sufficient to overcome the force of gravity separation 
and flocculation (Nam et al., 2010; Wooster, Golding, 
Sanguansri, 2008; Nemen, Lemos-Senna, 2011; Anton, 
Benoit, Saulnier, 2008; Yukuyama et al., 2016). The 
main physical instability of NE is the Ostwald ripening 
phenomena that consist in an increase in the average 
radius of the droplets when the droplets on the dispersed 
phase migrate to continuous phase by the process of 
mass transfer (Maruno, Rocha-Filho, 2009; Taylor, 2003; 
Urbina-Villalba et al., 2009). The NE breakdown depends 
on the physicochemical properties of phases (polarity, 
density and viscosity), the nature of the interfacial barrier 
(thickness, loading and chemical nature) and particle 
characteristics (size, concentration and physical state) 
(McClements, 2012).
These systems are thermodynamically unstable, 
in other words, they do not form spontaneously and 
the methods used involve low and high energy for 
emulsification (Pey et al., 2006; Sole et al., 2010; Karthik 
et al., 2015). The high-energy methods use mechanical 
shear stress to break up the oil and water phases to form 
nanosized droplets. The methods used in this case are high 
pressure homogenizers, microfluidizers or ultrasound 
(Kourniatis et al., 2010; Puglia et al., 2010; Nuchuchua 
et al., 2009; Sakulkua et al., 2009).
Despite the wide use of the high-energy methods 
in the cosmetic and pharmaceutical industry, the high 
cost of manufacturing devices may limit its applicability 
(Fortunato, 2005). Thus, simple and cheaper strategies to 
obtain NE are the use of low energy approaches based on 
the spontaneous emulsification (SE, also called solvent 
displacement or self-emulsification) of oil droplets 
in oil-water surfactant by modifying the composition 
or environment (Sajjadi, 2006; McClements, 2012; 
Yukuyama et al., 2016). Other low-energy methods occur 
due to temperature variations during the emulsification 
process (PIT - Phase Inversion Temperature) (Shinoda, 
Saito, 1969; Forgiarini et al., 2001; Morales et al., 2003) 
and maintaining the temperature constant and varying 
the composition of the system (PIC - Phase Inversion 
Composition or EPI – Emulsion Phase Inversion) 
(McClements, Rao, 2011).
NE have some advantages in relation to other systems. 
Compared to conventional emulsions (2-20 μm), which 
have a milky white appearance, NE feature a smaller 
droplet size (< 1μm) which gives them greater kinetic 
stability and translucent appearance (Tadros, Kessell, 
2004; Constantinides, Chaubal, Shorr, 2008; Gupta et al., 
2016). Unlike ME, NE requires low concentrations of 
surfactant (3% to 10%), which makes them less irritating 
to the stratum corneum (McClements, Rao, 2011). They are 
used instead of liposomes and vesicles, due to their greater 
stability, ability to encapsulate lipophilic drugs and ease of 
preparation on a large scale (Tadros, Kessell, 2004). They 
do not require the use of polymers and organic solvents 
such as polymeric NP in their preparation (Mäder, Mehnert, 
2005). It should be remembered that the components of 
NE are well tolerated by the body, where the oil droplets 
containing the lipid soluble drug are rapidly hydrolyzed 
by lipases in the gastrointestinal tract (Chakraborty et al., 
2009). Traditionally, NE were introduced in medicine to 
facilitate parenteral nutrition with fluids (Bhalodia, Shelat, 
2010). Today, thanks to the possibility of encapsulation and/
or adsorption of molecules, the small size of their droplets 
and their toxicological safety, NE are an excellent vehicle 
for delivering lipophilic compounds in cosmetics and drugs 
by ophthalmic, topical and oral routes (Mehnert, Mäder, 
2001; Lipinski, 2000; Pouton, 2006).
When administered orally, NE offer several benefits 
including sustained release, increased rate of absorption 
and therapeutic potency, toxicity and dose reduction of 
drug (Aboofazeli, Barlow, Lawrence, 2000; Oliveira et al., 
2004; Mason et al., 2006). Some of these advantages could 
be confirmed by Lin et al. (2012) who developed NE W/O 
containing amoxicillin prepared with chitosan and heparin 
and evaluated these formulations against Helicobacter 
pylori, and more significant results were obtained with the 
drug as suspension compared to the oral solution.
NE are considered very attractive for manufacturing 
topical application products, due to their transparency 
and fluidity. Appropriate concentrations of oil and no 
thickeners provide an even distribution of the product’s 
sensory aspect and make it pleasant to the touch. The 
small size of their droplets ensures greater wettability 
and spreadability, resulting in a high contact surface and 
rapid penetration of the active ingredients through the skin 
(Mehnert, Mäder, 2001; Bouchemal et al., 2004; Tadros, 
Kessell, 2004; Sonneville-Aubrun, Simonnet, L’alloret, 
2004; Zhou et al., 2010).
Such formulations may also promote the penetration 
of substances of therapeutic interest by means of natural 
fluidization of the skin since oils and surfactants present in 
the composition may unstructured the skin layers) favoring 
penetration (Tadros, Kessell, 2004; Sonneville-Aubrun, 
Simonnet, L’alloret, 2004). For topical administration, 
NE show high moisturizing ability and they are able to 
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release more water and applied agents on the skin than 
water alone or traditional vehicle. These processes reduce 
transepidermal water loss and intensify the penetration 
of active ingredient (Derle, Sagar, Pimpale, 2006). 
For the transdermal route, it is possible to increase the 
blood concentration of lipophilic drugs with low oral 
bioavailability. Thus, Shakeel et al. (2008) demonstrated 
that transepidermal absorption of NE containing celecoxib 
was 3.3 times higher than the oral formulation of this anti-
inflammatory drug.
Vegetable oils in nanoemulsions
The oily core of NE represents 2.5 to 20% of final 
composition and is typically composed of fatty esters or 
acids, triglycerides, alkanes, lipophilic active ingredients, 
silicone oils of mineral or vegetable type (Sonneville-
Aubrun, Simonnet, L’alloret, 2004; McClements, 2012; 
Vandamme, 2002; Wu, Guy, 2009). Features such as lack 
of toxicity, high physical stability and affinity for the active 
ingredient are important characteristics of the NE oil core 
that should be considered (Moraes et al., 2009).
Several studies are described in the literature to 
improve the therapeutic benefits of VO carried in NE when 
compared to conventional formulations or application 
of these compounds in crude form. In the Table I are 
described some studies with NE prepared with VO and 
its applications in vitro and in vivo, VO and surfactant 
concentrations, as well as methods of preparation.
Eucalyptus oil NE (Eucalyptus globulus) were 
prepared to analyze their potential against bacterial 
uropathogens Proteus mirabilis. The formulation obtained 
was stable, at centrifugation (3500 rpm, 30 minutes) and 
heating/cooling cycles (48 hours); transparent, with a 
droplet size of 20 nm; and an inhibition growth rate of the 
microorganism to 100%, compared to oil alone (Saranya, 
Chandrasekaran, Mukherjee, 2012). Another NE were 
developed with the same oil and evaluated its activity 
in relation to Staphylococcus aureus, a microorganism 
commonly found in skin lesions and wounds. The results 
TABLE I - Examples of in vitro and in vivo applications of NE prepared with VO available in the literature
Vegetable Oil (concentration) Surfactant (concentration) Method of preparation Application (Reference)
Clove (1%)
Polysorbate 80 (15%) 
Macrogol-8 glycerin  
caprilocaproil (15%) 
Glycerol triacetate (8%)
Aqueous phase 
titration
In vitro antibacterial activity 
(Anwer et al., 2014)
Andiroba (10%) 
Polysorbate 20 (1%) 
Polysorbate 80 (1%) 
Sorbitan monooleate (2%)
HPH In vitro antiparasitic activity (Baldissera et al., 2013)
Anise (25, 50 and 75% of oil 
phase) Soy lecithin (5%) HPH
In vitro antimicrobial activities 
(Topuz et al., 2016)
Argan Polyethoxylated solutol HS-15 EPI In vitro cytotoxic activity (Jordan et al., 2012)
Babassu (5%) Mixture of sorbitan monooleate and PEG-
54 castor oil (10%)
PIT
Pharmaceutical and cosmetic 
matrices (Gumiero, Filho,2012)
Carqueja-doce (3.32%) Polysorbate (0.77%) SE In vitro antifungal activity 
(Danielli et al., 2013) 
Casca-de-anta (4%) Polysorbate 20 (1%)
 
Sorbitan monooleate (1%)
HPH In vitro cytotoxic activity 
(Gomes et al., 2013)
Cinnamon (6%) Polysorbate 80 (18%) EPI In vitro antibacterial activity (Nirmala et al., 2013)
Cinnamon bark (1%)
Polysorbate 80 (3%) 
Polysorbate 20 (3%) 
Lauric arginate (0.375%)
PIT
In vitro antimicrobial activities 
(Hilbig et al., 2016)
Citronella (10%) 
Hairy Basil (5%) 
Vetiver (5%)
Mixture of cetearyl alcohol and cocoyl 
glucoside (5%)
HPH In vivo repellent activity (Nuchuchua et al., 2012)
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Vegetable Oil (concentration) Surfactant (concentration) Method of preparation Application (Reference)
Citronella (20%) Mixture of cetearyl alcohol and cocoyl 
glucoside (2.5%) 
HPH In vivo repellent activity 
(Sakulkua et al., 2009)
Curcuma (15%) Soya lecithin (21%)
 
Isopropyl alcohol (21%)
SE
In vivo anti-inflamatory activity 
and irritative potential analysis 
(Ali et al., 2012)
Eucalyptus (10%) Mixture of polysorbate 20 and ethyl 
alcohol (35%) 
EPI In vivo anti-inflammatory activity (Alam et al., 2013)
Eucalyptus (16.66%) Polysorbate 20 (16.66%) EPI In vivo and in vitro antibacterial activities (Sugumar et al., 2014)
Flaxseed (20%) Egg phosphatidylcholine (1.2%)
  
DSPE-PEG 2000 (0.3%)
SE In vitro cytotoxic activity 
(Ganta et al., 2008)
Grape seed (3.3%) 
Almond kernel (3.3%)
Polysorbate 80 (0.77%) 
Sorbitan stearate (0.77%)
SE 
Matrix for incorporation of 
benzophenone-3 
(Almeida et al., 2009)
Orange (5 and 10%) 
Orange Terpene (15%)
Mixture of lauric 2 EO, lauric 6 EO, lauric 
10 EO, lauric 23 EO and oleic 10 EO 
ethers (10%) 
HPH Matrix for incorporation (Kourniatis et al., 2010)
Palm kernel (7.14%) Lecithin (2.2%)
 
Macrogolglycerolricinoleate (1.24%)
HPH Anti-parkinsonian therapy (Zainol et al., 2012)
Palm kernel esters (4%) Lecithin (2.5%)
 
Polysorbate 80 (0.75%)
HPH In vitro antibacterial activity (Musa et al., 2013)
Pomegranate (1.5%) Sorbitan monoleate (10%) EPI Cosmetic matrix (Silva et al., 2013)
Rapeseed (5%)
Polysorbate 20 (0.12%) 
Polysorbate 60 (2.01%) 
Polysorbate 80 (5.32%) 
Sorbitan laurate (4.88%) 
Sorbitan stearate (2.99%) 
Sorbitan oleate (2.90%) 
Olelyl alcohol (1.90%) 
Oleyl alcohol (3.10%) 
Hydrogenated castor oil (2.58%)
PIT
Matrix for incorporation 
(Morais et al., 2006)
Rapeseed (56.5%) 
Salmon (8%) 
Mixture of polysorbate 80 and soya 
lecithin (10%)
HPH Cosmetic matrix (Kabri et al., 2011)
Rice (10%) Sorbitan monoleate (10%)
 
PEG-30 castor oil (10%)
EPI
In vivo psoriasis and atopic 
dermatitis activity 
(Bernardi et al., 2011)
Sucupira branca (5%) Polysorbate 80 (2.5 %)
 
Sorbitan monooleate (2.5%)
SE In vivo and in vitro larvicidal 
activity (Oliveira et al., 2016)
Tea Tree (1%) Polysorbate 80 (0.38%)
 
Sorbitan monooleate (0.38%)
SE In vivo antiedematogenic effect (Flores et al., 2015)
Tea tree (1%) Polysorbate 80 (0.38%)
 
Sorbitan monooleate (0.38%)
SE In vitro antifungal activity (Flores et al., 2011)
DSPE-PEG2000:1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy-(polyethyleneglycol)-2000]. EG: 
polyethyleneglycol. EO: ethylene oxide. EPI: emulsion phase inversion. SE: spontaneous emulsification. HPH: high pressure 
homogenization. PIT: phase Inversion Temperature.
TABLE I - Examples of in vitro and in vivo applications of NE prepared with VO available in the literature (cont.)
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showed complete loss of viability of microorganisms 
after 15 minutes of interaction with the formulation, 
which presented a greatly reduced droplet diameter 
(3.8 nm) (Sugumar et al., 2014). The antibacterial 
action of NE clove oil (Syzygium aromaticum L.) was 
also explored against Staphylococcus aureus, Bacillus 
subtilis, Proteus vulgaris, Pseudomonas aeruginosa and 
Klebseilla pneumonia comparing their activity against 
pure oil and amikacin standard. The results showed that 
the NE, with 29.1 nm diameter, were effective against all 
microorganisms requiring, approximately, half the dose 
to achieve the minimum inhibitory concentration (MIC) 
(MIC 0.075 to 0.300%) when compared to clove oil bulk 
(MIC, 0.130 to 0.500%) and amikacin (MIC 2 to16 mg 
mL-1) (Anwer et al., 2014).
The antifungal activity of carqueja doce oil 
(Stenachaenium megapotamicum (Spreng.) Baker) and its 
major component, thymol, both free and in nanoemulsified 
form, were tested in relation to eleven species of fungi 
using the broth microdilution method. The results showed 
that VO and thymol presented in vitro activity against 
antidermatophytic fungis Epidermophyton floccosum, 
Trichophyton rubrum, and Scytalidium dimidiatum. A 
significant reduction in MIC and minimum fungicidal 
concentration (MFC) were observed for the NE of the 
oil, with a diameter of 210 nm, against Epidermophyton 
floccosum and Trichophyton rubrum, when compared to 
oil and thymol, demonstrating the improved oil activity 
when nanoencapsulated (Danielli et al., 2013).
The antifungal activity of tea tree oil (Melaleuca 
alternifolia), incorporated into NE and polymeric NC, 
was investigated for the growth of dermatophyte fungus 
caused by Trichophyton rubrum. The study was performed 
in two different in vitro models of dermatophyte nail 
infection using both formulations proposed and a reference 
emulsion such as a control. In the first experiment, a sterile 
nail powder was put into a 96-well plate and remained 
in contact with T. rubrum for later treatment with the 
formulations. In the second, sterile nail fragments were 
placed in sterile Petri dishes with their external sides on 
filter paper soaked with the formulations. All formulations 
presented a significant decrease in cell count in the first 
week after treatment (2.37, 1.45 and 1.0 log CFU mL-1 for 
emulsion, NE and NC, respectively). The antimicrobial 
effect of tea tree oil NC was clearly pronounced in relation 
to the other samples. The diameter of the fungal colonies 
(2.88 mm2, 14.59 mm2, 40.98 mm2 and 38.72 mm2 for 
the NC, NE, emulsion and untreated nail, respectively) 
revealed that NC promoted a minimal growth of the 
fungi. Nail infection models demonstrated the ability of 
the formulations to reduce T. rubrum growth, with the 
inclusion of oil in NC being most efficient, which can be 
explained by differences in structural organization and 
composition of the systems (Flores et al., 2013).
The same author (Flores et al., 2015) also assessed 
the antiedematogenic effect of tea tree oil (Melaleuca 
alternifolia) in nanocapsules and nanoemulsions 
incorporated into hydrogels. In this work the hydrogels 
were prepared using Carbopol® Ultrez, containing these 
nanocarriers, and evaluated their in vivo efficacy in 
protecting skin damage induced by UVB and cutaneous 
wound healing. The in vivo antiedematogenic effect was 
evaluated by ear thickness measurement after UVB-
irradiation. Randomly chosen animals were divided into 
groups of six and topically treated on the ear surface 
with 0.06 g of hydrogels with nanostructures (HG-TTO-
NC and HG-TTO-NE), free oil (HG-TTO) and control 
formulations (HG-C-NC, HG-C-NE and HG). The 
formulations were applied 1 h before irradiation of the 
ear surface and also 4 h after irradiation as previously 
described. An untreated irradiated control group was also 
included in the experiment. After 24 h of ear irradiation, 
the changes in ear thickness were measured. Hydrogels 
containing TTO-NC and TTONE (HG-TTO-NC and HG-
TTO-NE) were able to reduce significantly the ear edema 
after the exposition of the UVB radiation. A reduction of, 
approximately, 70% was obtained for HG-TTO-NC and 
HG-TTO-NE in relation to the untreated group. On the 
other hand, neither hydrogels containing free oil (HG-
TTO) nor formulations without oil (HG-C-NC, HG-C-NE 
and HG) reduced the ear thickness induced by light UVB.
Andiroba (Guaianensis carapa) and aroeira 
(Schinus molle) oils were used in association to prepare 
NE, which were analyzed for antiparasitic activity against 
Trypanosoma evansi using the blood of mice infected with 
the parasite. The tests were conducted with pure oils and 
NE at concentrations of 0.5% and 1%, at 1, 3 and 6 hour 
intervals. After 1 hour of assay, at lower concentrations it 
was observed that the number of live parasites was reduced 
by 81% and 94%, by pure oil and NE, respectively. 
With the 1% concentration in both formulations, no 
living parasite was observed during this period. After 
the experiment had been going on for 3 and 6 hours, all 
microorganisms were dead. The results demonstrate that 
these oils can be more effective against T. evansi, when 
prepared as NE (Baldissera et al., 2013).
The cytotoxic potential in vitro of NE containing 
casca-de-anta (Drimys angustifolia Miers and Drimys 
brasiliensis Miers) was evaluated on human glioblastoma 
(U-138 MG) and bladder carcinoma (T24) cell lines 
NE of VO from two species using the tetrazolium salt 
3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium 
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bromide (MTT) method. Opalescent bluish NE, with 
droplet diameters of 168 nm (D.angustifolia) and 181 
nm (D. brasiliensis) were obtained. The NE of both oils 
were not active on the U-138 MG, but had significant 
cytotoxicity effects towards the T24 lineage. Then, 
this study found that, these encapsulated oils showed 
a significant improvement in cytotoxic activity against 
tumor cells compared to their pure form (Gomes et al., 
2013).
In vivo studies have been performed to show the 
benefits of nanoencapsulated VO (Table 1). Turmeric oil 
(Curcuma longa) is widely researched due to its numerous 
therapeutic properties, including the anti-inflammatory 
activity which can be useful to treat chronic diseases such 
as psoriasis. For this reason, Ali et al. (2012) evaluated 
the anti-inflammatory potential of curcuma oil in NE, 
employing the carrageenan-induced paw edema in rats 
and Hen Egg’s on the Choriallantoic Membrane model 
(HET-CAM). The results showed that NE were stable 
during the 90 day study, presented a diameter of 56.05 nm, 
inhibited 70.35% of the edema formed and, besides that 
did not induce irritation.
Another oil used in the treatment of psoriasis and 
atopic dermatitis is rice oil (Oryza sativa). Because of 
its antioxidant and emollient effects, this VO has been 
used by the cosmetic industry in products to prevent 
skin aging, sun protection and treatment of skin diseases 
(Coppini et al., 2001; Patel, Naik, 2004; Lerma-García et 
al., 2009). Knowing these advantages, NE with rice oil 
were developed and physical stability, irritancy activity on 
HET-CAM model and skin moisture potential in healthy 
volunteers were analyzed. The results showed that the 
formulations were stable during 90 days, non-irritating, 
increased moisturizing in 38% of normal skin volunteers 
and 30% in subjects with skin problems. The nanosized 
droplets (69 nm) improved the adherence formation of a 
dense film on the skin which prevents evaporation of the 
water. This justifies the use of rice bran oil NE developed 
as an adjuvant for the treatment of psoriasis and atopic 
dermatitis (Bernardi et al., 2011).
Citronella oil (Cymbopogon nardus) has been 
extensively studied due to its repellent effect against 
mosquitoes (Trongtokit et al., 2005; Kim et al., 2005; 
Müller et al., 2008; Yang, Ma, 2005). It is considered 
effective when used alone at concentrations of 0.05% to 
15%, in combination with natural or synthetic repellent 
compounds (Fradin, Day, 2002). NE containing this oil 
were prepared by high pressure homogenization (HPH) 
with varying amounts of surfactant and glycerol, and 
studied regarding the droplet size, stability, release 
characteristics and in vivo repellent activity against Aedes 
aegypti. A decrease in droplet size was observed at a 
glycerol of 0 and 50%, from 164 to 139nm, and surfactant 
concentration of 2.5% to 10%, from 178 to 135 nm. 
However, an increased droplet size and phase separation 
was found with 75% and 100% of glycerol. An increase 
in surfactant concentration led to decreasing droplet size, 
increasing homogeneity and protection time. Moreover, 
the release of citronella oil from a high amount of glycerol 
was much slower than that from the low amount, resulting 
in sustained mosquito protection time (Sakulkua et al., 
2009).
The in vivo repellent activity against Aedes aegypti 
by citronella oil (Cymbopogon nardus) combined with VO 
of hairy basil (Ocimum americanum) and vetiver (Vetiveria 
zizanioides) was also investigated by Nuchuchua et al. 
(2009). The NE were prepared with and without HPH. 
The results demonstrated that the formulations prepared 
by HPH showed a smaller droplet size, 150-160 nm, higher 
zeta potential (ZP), -45 to -61 mV, stability, during 2 
months, and significantly longer mosquito protection times 
than those prepared without the homogenization. The 
repellant effect of the NE (4.7 hours) could be attributed 
to a major difference in oil droplet size. Therefore, the 
small droplet size of NE prepared with HPH would play 
an important role on their efficacy.
The Sucupira oil has also been studied as their 
larvicidal activity by Oliveira et al. (2016). Pterodon 
emarginatus Vogel is a Brazilian species that belongs to 
the family Fabaceae, popularly known as Sucupira or 
Sucupira branca. Its oil has several biological activities, 
including potent larvicidal property against Aedes aegypti 
and this study describes the development of a novel 
nanoemulsion with larvicidal activity against A. aegypti. 
The NE were prepared by SE with concentration of 5% 
of Sucupira oil, and presented nanometric diameter with 
low polydispersity. To the larvicidal assay, Aedes aegypti 
larvae were obtained from the Arthropoda Laboratory 
(Universidade Federal do Amapá, Brazil). Biological 
assay was performed under controlled conditions, 
using fourthinstar larvae kept at 25 ± 2 °C, under 
relative humidity of 75 ± 5% and a 12h light:dark cycle. 
Optimized P. emarginatus nanoemulsion was diluted in 
distilled water at 250, 100, 75, 50, 25, 12.5 ppm (relative 
to P. emarginatus oil). Control group was treated with 
deionized water. Mortality levels were recorded after 24 
and 48 hours of exposure. The groups of larvae treated 
with optimized P. emarginatus nanoemulsion at 250 ppm 
presented mortality level of 100%. Moreover, it could 
be suggested that the mechanism of action may involve 
reversible inhibition of acetylcholinesterase and that the 
nanoemulsion may be safe for mammals.
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NE containing eucalyptus oil (Eucalyptus globulus) 
were evaluated in relation to wound healing activity 
and irritation potential in rats. A dose of 100 µL of NE 
or irritating pattern of 0.8% formalin was injected once 
daily into 5 cm2 in the back of the rats divided into three 
groups (control, standard irritant, NE). The development 
of erythema and edema was monitored daily during 3 days. 
After completion of the test, the animals were sacrificed 
and their skins removed for biopsy. In healing action 
test four groups of rats which, after anesthesia had their 
backs shaved to create a 300 mm2 lesion were used. They 
were treated with the standard NE and neomycin, where 
every two days, 1 mL of each product was reapplied and 
the reduction of the lesion observed. The results proved 
to be no irritant action of NE, which can be confirmed 
by histopathological examination. With the NE it was 
shown that by the 16th day 100% of the treated lesion was 
cured, compared to the 94.2% cure rate observed in both 
untreated (control) and neomycin treated rats (Sugumar 
et al., 2014).
Polyunsaturated fat ty acids (PUFA) argan 
oil (Argania spinosa) NE prepared using a 32 full 
factorial design, various emulsifying mixtures and 
polyethyleneglycol vitamin E succinyl ester (TPGS), 
were tested for cytotoxic properties in murine breast and 
colon carcinoma cells. In addition, a biocompatibility 
screen was evaluated using normal vascular myocytes 
and areolar fibroblasts. Adverse effects on the integrity 
of test cultures were only noted at high TPGS content in 
the emulsifier system, exceeding 80%. The IC50 values 
of the combination argan oil and TPGS (40–80% w/w, 
emulsifiers) were 5 - 9 fold lower compared to TPGS-free 
and argan oil-free control NE. Argan oil NE, stabilized with 
vitamin E TPGS and solutol HS mixtures, demonstrated 
significant pro-apoptotic effect on both test cancer cell 
lines, indicating built-in anticancer properties for such an 
NE platform, potentially enhancing overall antineoplastic 
effects of incorporated candidate chemotherapeutic agents 
(Jordan et al., 2012).
Most often, VO are incorporated into NE, not just 
for nanoencapsulating several therapeutic classes of drugs 
inside an oil core, but also to enhance the action of these 
compounds. This feature also enables the use of much 
lower concentrations of active substances eliminating 
problems related to toxicity, resistance and side effects. 
Based on this fact, the interest of research groups in 
developing NE mixture of VO and drugs has grown in 
recent years. 
A topical clobetasol-loaded NE (0.05%) containing 
eucalyptus oil (Eucalyptus globulus) were developed to 
relieve inflammation caused by psoriasis and evaluated its 
efficacy against different types of in vivo studies. The anti-
inflammatory activity of the optimized NE was evaluated 
by the carrageenan-induced hind paw edema method in 4 
groups (control, placebo, NE, marketed cream) of rats (n = 
6). Formulations were applied on the dorsal area of 9 cm2, 
0.5 h before carrageenan injection, and paw volume was 
measured during 12 h. A skin irritation test was performed 
in 3 groups (n = 6) through application of a single dose 
of 10 ml (NE, placebo, marketed cream) in the left ear of 
the rat and the right ear as a control. The development of 
erythema was monitored for 14 days. A contact dermatitis 
test was performed in 5 groups (vaseline, control, 
placebo, NE, marketed cream) of rats (n = 8), which after 
tricotomization were sensitized with nickel sulfate in the 
abdomen, except the first group which received only solid 
vaseline. After final treatment (5 days), the animals were 
euthanized and the blood was collected by cardiac puncture 
to determine the NTPDase activity of lymphocytes by the 
Coomassie Blue method, using bovine serum albumin as 
the standard. The results concluded that the optimized 
NE shows a maximum inhibition of edema, which does 
not occur with the placebo and marketed cream; low 
irritation score hence it is safe for human use, and did not 
appear to stimulate an inflammatory or immune response 
using the contact dermatitis model (Alam et al., 2013).
Development of multidrug resistance against a 
variety of conventional and novel chemotherapeutic 
agents is a significant challenge in effective cancer therapy 
(Szakacs et al., 2006). The VO, such as flaxseed oil (Linum 
usitatissimum L.), has been used due to the presence of 
omega-3 and omega-6 fatty acids which show interesting 
biological properties including cancer chemopreventive 
effects (Rose, Connolly, 1999). Thus, NE of paclitaxel 
(PTX) drug and curcumin (CUR) powder, encapsulated 
in flaxseed oil, were developed and in vitro cytotoxic 
activity was evaluated in drug sensitive (SKOV3) and 
drug resistant (SKOV3TR) human ovarian adenocarcinoma 
cells. The intracellular deliveries of drugs by NE lead 
to downregulation of P-gp and inhibition of nuclear 
factor kappa B (NFκB) pathway, enhancement the cell-
kill efficacy and the apoptotic response. The optimized 
flaxseed oil NE consisted of PTX or CUR (0.2% w/v). 
Additionally, poly-(ethylene glycol) (PEG) modified NE 
were prepared by incorporating DSPE-PEG2000. The oil 
droplets were spherical and uniform with a size below 
150 nm, and ZP range of -35.37 mV and -44.53 mV. The 
formulations were effective in delivering the PTX and 
CUR alone or combined into to the cells. These results 
indicate that CUR could potentiate the apoptotic effects of 
PTX against SKOV3 and SKOV3TR cells. Thus, this co-
therapy strategy holds significant promise for the clinical 
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management of refractory diseases, especially in ovarian 
cancer (Ganta et al., 2008).
NE of azithromycin and cinnamon oil (Cinnamomum 
zeylanicum) were developed aiming to improve drug 
solubility in the lipophilic oil chosen. In this case, 
the pre-procedure preparation step includes prior 
solubilization, overnight, of azithromycin in oil, followed 
by centrifugation to ensure complete solubilization. The 
formulation obtained exhibited fine droplets (68.39 ± 
2.19 nm), low polydispersity index (PDI) (0.158 ± 0.07), 
conductivity (0.130 ± 0.13 mS/cm), and stability for 48 
hours. The low surfactant concentration as compared to 
ME has the advantage of causing less gastrointestinal 
irritation (Nirmala et al., 2013).
The response surface methodology (RSM) is a 
statistical tool used to help develop and optimize new 
formulations through experimental design, allowing 
the evaluation of all potential factors simultaneously. 
It was used by two research groups to develop NE of 
levodopa with palm kernel oil (Elaeis guineensis) and 
chloramphenicol with palm kernel oil esters (mixture 
of sesame, soybean, sunflower, safflower seed, and 
pine nut oils), both prepared by HPH. Palm kernel oil 
based NE containing levodopa were developed with 
different concentrations of a mixture containing VO and 
medium-chain triglyceride oil, lecithin, macrogolglycerol 
ricinoleate, and addition rate. The variables tested showed 
formulations with large droplets by increasing lecithin 
concentration and oil addition rate, and high ZP by 
reducing the addition rate and a higher proportion of oil. 
The optimum levodopa NE, obtained in an addition rate 
of 5.5 mL/min, with droplet size and ZP, 104.04 nm and 
−29.18 mV, respectively, were stable during 6 months 
(Zainol et al., 2012). The chloramphenicol-loaded NE 
palm kernel oil esters were developed by evaluation 
of different levels of oil, lecithin and glycerin. It was 
observed that the droplets sizes were most affected by 
the amount of oil, while the proportions of lecithin and 
glycerin modified ZP and osmolarity (Musa et al., 2013).
Studies on NE prepared with VO of babassu, 
rapeseed, rapeseed/salmon, orange/terpene orange, tea 
tree, grape seed/almond kernel and pomegranate were 
also developed for their use as potential matrices for 
incorporation of cosmetic and/or pharmaceutical active 
elements.
Babassu oil NE (Orbignya oleifera) were prepared 
employing the PIT method. During the process of 
preparation different temperatures were tested, but only 
75 ± 5 ºC provided stable formulations, with transparent 
bluish luster. The NE obtained were submitted to 
preliminary stability tests of centrifugation, thermal stress, 
and heating/cooling cycles. Only the stable formulations 
in the centrifuge test, using 1000, 2500, and 3500 rpm, 
for 15 minutes at each speed, were submitted to other 
tests. The thermal stress test was conducted at a range of 
temperatures (from 40 ºC up to 85 ± 2 ºC) for 30 minutes, in 
each condition. In the heating/cooling cycles the samples 
were submitted to air stove (45 ± 5 ºC) and to refrigerator 
(4 ± 2 ºC), both during 24 hours, completing six cycles 
(12 days) that were performed in all. The NE obtained 
were considered stable across all cycles of temperature 
studied, since no significant variations were observed in 
droplet size (40 - 50 nm), PDI (0.091 to 0.110), pH (6.2 to 
6.5) and conductivity (280 - 29 mS/cm) in relation to the 
initial values  of the study. The pH similar to skin allows the 
use of these NE as promising matrices for body hydration 
(Gumiero, Filho, 2012).
The PIT and EPI methods were used to prepare 
NE consisting of rapeseed oil (Brassica napus L.). 
Physicochemical characteristics such as droplet size, ZP, 
and pH were evaluated before and after thermal stress 
(50 ºC up to 80 ºC, during 30 minutes) and accelerated 
stability testing (4 ºC, 25 ºC, and 45 ºC, during 30 days). 
Only the samples that did not show signs of instability 
after the centrifugation test (1000, 2500, and 3500 rpm, 
during 15 minutes, at room temperature) were subjected 
to the stability test. Since the PIT temperature was 90 ± 
2 °C it was not possible to use this method, because the 
oil might degrade and the system might coalesce. Thus, 
NE containing a mixture of ten types of surfactant were 
prepared by the traditional EPI method, at 70 ± 2 °C, using 
mechanical stirring 400 rpm. An analysis of variance 
(ANOVA) was used to analyze the results. The thermal 
stress did not demonstrate significant influence on droplet 
size (215 nm to 233 nm), ZP (-49.54 to -37.04 mV), and 
pH (6.35 to 6.51). The result obtained in the stability test, 
did not show significant variation of droplet size and 
pH values, but the ZP values were little affected by high 
temperatures applied. In general, the NE obtained can be 
considered quite stable (Morais et al., 2006).
NE containing rapeseed oil (Brassica napus L.), 
salmon oil (Salmo salar) and caprylic/capric triglyceride 
were prepared in order to mask the odor of fish oil. The 
ideal blend of rapeseed oil, salmon oil and caprylic/
capric triglyceride showed droplet size 143 nm, PDI 
0.16, and electrophoretic mobility between -3 and -4 
mM cm/Vs. It was found that the turbidity of the samples 
depends on the concentration of rapeseed oil and caprylic/
capric triglyceride. All NE showed Newtonian behavior, 
suggesting therefore that the surfactants do not affect the 
formulation rheology. It was concluded that rapeseed and 
salmon oil showed melting points close together, however 
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salmon oil changes from a liquid to a solid close to 5 °C, 
while the caprylic/capric triglyceride between 29 ºC and 
28 ºC. It was also observed that for each formulation the 
crystallinity and melting temperatures vary according to 
the proportion of these two oils, and also of the surfactants 
(Kabri et al., 2011).
The influence of the HPH method used to obtain 
dispersions with small droplet size, with or without the 
presence of surfactants, such as ethoxylated lauryl ether 
(line Unitol L®) and ether ethoxylated oleic acid (line 
Unitol O®), was analyzed during the preparation of orange 
oil (Citrus sinensis) and orange terpene loaded-NEs. The 
ideal HLB values for dispersions of orange and terpene 
oils obtained were, respectively, 6.4 (Unitol L20®) and 8.7 
(Unitol L100®/Unitol L20®). The average droplet size for 
orange oil (300 to 3000 nm) and terpene dispersions (300 
to 1000 nm) was similar when prepared in 17.500 psi, and 
1 to 4 cycles. All dispersions showed phase separation 
less than 1h, after HPH processing. The orange oil (15% 
w/w) NE with droplet size between 10 and 60 nm was 
obtained only with Unitol L60® (10% w/w), using 3 cycles 
of 5000, 10.000 and 17.500 psi. The terpene oil (15% 
w/w) NE showed a rapid phase separation, due to the high 
hydrophobicity of this oil. As a result, increased pressure 
processing in HPH (5000-17500 psi) causes a small 
variation in the droplet size dispersions. On the other hand, 
it was observed in the systems prepared in the absence of 
surfactant that the processing time may promote greater 
dispersion of droplet size, thereby reducing its stability 
(Kourniatis et al., 2010).
Nanoencapsulation in NE and polymeric NC 
was the artifice used to protect tea tree oil (Melaleuca 
alternifolia) against volatilization. Both formulations 
appeared macroscopically homogeneous and similar 
to opalescent bluish liquids. The NE and NC presented 
nanometric mean diameters (160-220 nm) as well as 
PDI below 0.25 indicating an adequate homogeneity of 
these systems. The formulations showed acid pH (5.9 
- 6.5) and negative ZP (about -13 mV). Moreover, the 
type of oily phase used in the preparation of the colloidal 
systems may be influenced by the ZP values (in module) 
obtained. The transmission electron microscopy (TEM) 
analysis showed homogeneous and spherical particles 
with similar diameters as determined by photon correlation 
spectroscopy. The yield of oil obtained was 96.0 ± 0.3%, 
for NE, and 95.7 ± 0.6%, for NC of the theoretical 
concentration, and only 4% of the oil was lost during the 
preparation, probably during the evaporation of organic 
solvent. The odor intensity was NC < NE < emul sion < 
pure oil. Due to the presence of the polymeric wall in 
the NC, these systems were considered more adequate 
to avoid the volatilization of the oil. Moreover, NE also 
showed a protection against oil volatilization compared 
to the coarse emulsions, although this provided less 
protection than that observed for NC (Flores et al., 2011).
Benzophenone-3 was used to prepare NE and 
polymeric NC with oil phase composed by grape seed 
oil and almond kernel oil. All formulations appeared 
macroscopically homogeneous and their aspects were 
similar to a milky bluish opalescent fluid. Both NE and 
NC presented a mean particle size in the nanometric range 
(220 - 280 nm), acidic pH and negative ZP (between -6.0 
and -9.0 mV). NC presented a narrowed particle size 
distribution, as can be observed by their lower PDI (0.19 
- 0.20) compared to NE (0.27 - 0.30). The TEM images 
revealed that NC and droplets of NE were spherical in 
shape. The results obtained after the benzophenone-3 
was entrapped were similar to those presented by the 
unloaded-systems showing that the presence of the 
sunscreen did not modify the colloidal characteristics of 
both systems. After 6 months of storage, unloaded-NC and 
NE showed similar mean particle size and PDI compared 
to the initial characteristics. The encapsulation efficiency 
of benzophenone-3 loaded in NE and NC was not altered 
during the storage time, presenting values close to 100%, 
such as in the initial test. Benzophenone-3 showed a high 
photostability under UVC radiation, during 7 days, due 
to protection exerted by the oil phase of NC and NE. 
Thus, these VO could be an interesting alternative to be 
used in the development of dermatological and cosmetic 
formulations (Almeida et al., 2009).
The oil from the seeds of the pomegranate (Punica 
granatum L.) is a compound with potential use in 
cosmetics as a moisturizer and/or antioxidant. However, 
HLB is unknown to this oil, but it is an important property 
for stabilization of dispersed systems. For this purpose, 
NE were prepared with this VO and a mixture of different 
proportions of surfactants. The most stable NE was 
obtained with HLB equal to 7.51, droplet size 211 nm, 
viscosity 1.43 cP, pH 6.5, ZP (-18 mV), and stability during 
90 days (Silva et al., 2013).
CONCLUSION
According to the literature, it is clear that studies 
addressing NE with oil core-based VO are a topic of 
growing interest topic in scientific circles in recent years, 
with a significant increase in the number of publications 
between the years 2006 and 2014. Analyzing them it was 
revealed that eucalyptus oil was used as the most oily core 
NE, followed by citronella oils, flaxseed and palm kernel. 
The most researched therapeutic activities in oils NCs 
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were antibacterial and anti-inflammatory, which has been 
proved through studies in vitro and in vivo. The number of 
in vitro studies exceeds in vivo due to its practicality and 
cost. The method of preparation most commonly used in 
the emulsification was phase inversion, followed by HPH, 
employing the surfactant polysorbate 20, polysorbate 80, 
and lecithin.
Thus, it is concluded that the development of 
natural compounds containing NE can be affected by a 
number of factors, and therefore the formulation of the 
VO, surfactant types or any other system should not be 
performed randomly. It is also necessary to know well the 
characteristics and concentrations of all the components 
involved, as well as details of each methodology. It is 
known that the preparation of this nanoformulation is very 
laborious. Thus, one way to optimize the work is to analyze 
the parameters and results of previously published works, 
as proposed by this article.
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